ATRA - Atara Biotherapeutics Inc
IEX Last Trade
7.56
0.500 6.614%
Share volume: 78,556
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$7.06
0.50
7.08%
Summary score
28%
Profitability
25%
Dept financing
23%
Liquidity
37%
Performance
30%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-71.19%
Return on assets
-21.31%
Return on sales
-4838.36%
Return on invested capital
1002.31%
Total debt ratio
61.9%
Debt ratio change over timeo
-0.46%
Current Ratio
4.34%
Quick Ratio
3.84%
Cash Position Ratio
3.52%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-180.86%
Return on assets
-30.25%
Return on sales
-3060.66%
Return on invested capital
4325.23%
Total debt ratio
135.84%
Debt ratio change over timeo
1%
Current Ratio
1.28%
Quick Ratio
1.19%
Cash Position Ratio
0.99%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
32.3%
Return on assets
-18.91%
Return on sales
-114.22%
Return on invested capital
26.06%
Total debt ratio
159.48%
Debt ratio change over time
1.07%
Current Ratio
0.59%
Quick Ratio
0.5%
Cash Position Ratio
0.26%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-61.41%
Return on assets
-112.03%
Return on sales
-200.44%
Return on invested capital
-377.68%
Total debt ratio
-45.97%
Debt ratio change over time
-0.46%
Current Ratio
-0.59%
Quick Ratio
-0.18%
Cash Position Ratio
-0.42%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ATRA | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -71.19% | 13.79% | 34.47% | 7.43% |
| Return on assets | -21.31% | 2.76% | 3.15% | 5.62% |
| Return on sales | -4838.36% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | 1002.31% | 2.36% | 5.39% | 19.77% |
| Profitability | 25% | 40% | 59% | 56% |
| Total debt ratio | 61.9% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -0.46% | 308.97% | -6.99% | 1.18% |
| Dept financing | 17% | 50% | 25% | 7% |
| Current Ratio | 1.28% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 1.19% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 0.99% | 0.36% | 1.28% | 2.93% |
| Liquididy | 74% | 12% | 28% | 64% |
| Short-term ratios | ATRA | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -180.86% | 13.77% | 13.25% | 3.8% |
| Return on assets | -30.25% | 2.43% | 1.89% | 3.09% |
| Return on sales | -3060.66% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | 4325.23% | 2.14% | 3.39% | 9.18% |
| Profitability | 25% | 65% | 59% | 57% |
| Total debt ratio | 135.84% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | 1% | 46.38% | -72.08% | 1.51% |
| Dept financing | 26% | 42% | 17% | 5% |
| Current Ratio | 1.28% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 1.19% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 0.99% | 0.36% | 1.28% | 2.93% |
| Liquididy | 21% | 12% | 31% | 75% |